Skip to main content

TSC1 clinical trials at UCSF

1 research study open to eligible people

TSC1 is a study at UCSF for patients with certain types of cancer. The trial is testing nab-sirolimus for adult and adolescent patients with malignant solid tumors. You may be eligible if you have specific changes in your TSC1/TSC2 genes and have already received standard treatment.

Showing trials for

Our lead scientists for TSC1 research studies include .

Last updated: